sTMS mini is a dual migraine therapy. Your patients can treat a migraine attack, and with daily treatment prevent future attacks. sTMS mini is so well-tolerated patients are encouraged to treat to effect. There are plenty of pulses available for you and your patient to work together to optimize treatment effect.
For acute treatment patients are encouraged to treat with up to 4 sequential pulses at the earliest indication of an attack. After a brief pause if they do not experience adequate symptom relief they can treat again as needed.
For prevention, patients are encouraged to treat with up to 4 pulses twice daily. Like most preventive migraine therapy, efficacy builds over time.
As with most migraine therapy, efficacy of central neuromodulation builds over time. Patients should adhere to a treatment protocol for at least 3 months before adjusting therapy.
The most commonly reported device related adverse events: lightheadedness (3.7%), tingling (3.2%), and tinnitus (3.2%) these typically resolve immediately after treatment. There have been no serious adverse events reported.
sTMS mini is contraindicated for patients with conductive metal implants in the head and neck, excluding dental work. MRI protocols may be a reasonable guide in assessing the safety of sTMS mini in patients with metal implants in the head and neck.